From: Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
Group
Adjuvant
SNT titers
Against SwH1N1
Against SwH3N2
A
–
B
C
Alhydrogel 2.0%
D
AddaVax™
E
CAF01
1:10
F
Diluvac Forte®
1:40